Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women

Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

(2018) Signe Borgquist et al.   Cancer Prevention Research

Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal

(2018) Shi-Yi Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs

(2018) Anna Diana et al.   Current Oncology Reports

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

(2017) Carolyn Taylor et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis

(2017) Yi-Jhih Huang et al.   Journal of Thoracic Oncology

Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients

(2016) Trine Grantzau et al.   RADIOTHERAPY AND ONCOLOGY

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

(2016) Erik S. Linklater et al.   Oncotarget

Non–Small-Cell Lung Cancer After Breast Cancer: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes in 3529 Women

(2014) Michael T. Milano et al.   Journal of Thoracic Oncology

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

(2013) G. D. L. Phillips et al.   CLINICAL CANCER RESEARCH

HER2 and lung cancer

(2013) Lorenza Landi et al.   Expert Review of Anticancer Therapy

Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked

(2013) Julien Mazières et al.   Journal of Thoracic Oncology

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

(2013) Edward B. Garon et al.   Journal of Thoracic Oncology

Estrogenic Steroid Hormones in Lung Cancer

(2013) Jill M. Siegfried et al.   SEMINARS IN ONCOLOGY

Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada

(2013) S. A. Lother et al.   Hormones & Cancer

The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status

(2012) Sara J. Schonfeld et al.   CANCER CAUSES & CONTROL

Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens

(2012) Laura P. Stabile et al.   CARCINOGENESIS

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens

(2011) Christine Bouchardy et al.   CANCER

Characteristics of Second Primary Lung Malignancy in Patients with Known Breast Cancer

(2011) Faraz Kerendi et al.   SOUTHERN MEDICAL JOURNAL

Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer

(2010) Monika L. Burness et al.   CANCER JOURNAL

Characteristics of triple-negative breast cancer

(2010) Tim C. de Ruijter et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

(2009) Rowan T Chlebowski et al.   LANCET

Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan

(2008) K.-D. Lee et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effect of Breast Cancer Radiotherapy and Cigarette Smoking on Risk of Second Primary Lung Cancer

(2008) Elizabeth L. Kaufman et al.   JOURNAL OF CLINICAL ONCOLOGY

Association Between Estrogen Receptor-β Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung

(2008) Naohiro Nose et al.   JOURNAL OF CLINICAL ONCOLOGY